BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 30408385)

  • 1. Gestational Trophoblastic Neoplasia and Pregnancy Outcome After Routine Second Curettage for Hydatidiform Mole A Retrospective Observational Study.
    Kan M; Yamamoto E; Niimi K; Tamakoshi K; Sekiya Y; Nishino K; Ino K; Kikkawa F
    J Reprod Med; 2016 Aug; 61(7-8):373-379. PubMed ID: 30408385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
    Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
    Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a routine second curettage for hydatidiform mole: a cohort study.
    Yamamoto E; Nishino K; Niimi K; Watanabe E; Oda Y; Ino K; Kikkawa F
    Int J Clin Oncol; 2020 Jun; 25(6):1178-1186. PubMed ID: 32144509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of hydatidiform mole using prophylactic chemotherapy and hysterectomy for high-risk patients decreased the incidence of gestational trophoblastic neoplasia in Vietnam: a retrospective observational study.
    Yamamoto E; Trinh TD; Sekiya Y; Tamakoshi K; Nguyen XP; Nishino K; Niimi K; Kotani T; Kajiyama H; Shibata K; Le QT; Kikkawa F
    Nagoya J Med Sci; 2020 May; 82(2):183-191. PubMed ID: 32581399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
    Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
    BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review.
    Braga A; Maestá I; Short D; Savage P; Harvey R; Seckl MJ
    BJOG; 2016 Jul; 123(8):1330-5. PubMed ID: 26444183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between vacuum aspiration and forceps plus blunt curettage for the evacuation of complete hydatidiform moles.
    Sato A; Usui H; Shozu M
    Taiwan J Obstet Gynecol; 2019 Sep; 58(5):650-655. PubMed ID: 31542087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
    Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ
    Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-analysis.
    Albright BB; Shorter JM; Mastroyannis SA; Ko EM; Schreiber CA; Sonalkar S
    Obstet Gynecol; 2020 Jan; 135(1):12-23. PubMed ID: 31809433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of laparoscopic surgery in the diagnosis of suspected gestational trophoblastic neoplasia cases with uterine mass].
    Li X; Feng F; Xiang Y; Wan X; Ren T; Yang J
    Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):910-4. PubMed ID: 26887874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
    Kim BW; Cho H; Kim H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH
    Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple pregnancy with complete hydatidiform mole and coexisting normal fetus in a retrospective cohort of 141 patients.
    Hajri T; Massoud M; Vergne M; Descargues P; Allias F; You B; Lotz JP; Haesebaert J; Bolze PA; Golfier F; Massardier J
    Am J Obstet Gynecol; 2024 Mar; 230(3):362.e1-362.e8. PubMed ID: 37722570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
    Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
    Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women with a partial mole during their first pregnancy and diagnosed earlier in gestation are at increased risk of developing gestational trophoblastic neoplasia.
    Worley MJ; Joseph NT; Berkowitz RS; Goldstein DP
    Int J Gynecol Cancer; 2014 Jun; 24(5):941-5. PubMed ID: 24819660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of previous cesarean section (C/S) on the risk for post-molar gestational trophoblastic neoplasia (GTN).
    Cho HW; Ouh YT; Min KJ; Lee NW; Lee S; Song JY; Hong JH; Lee JK
    Gynecol Oncol; 2020 Mar; 156(3):606-610. PubMed ID: 31954533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined analysis of clinical features, human chorionic gonadotropin (hCG) value, and hCG ratios for early prediction of postmolar gestational trophoblastic neoplasia.
    Rakprasit C; Ruengkhachorn I; Therasakvichya S; Inthasorn P; Achariyapota V; Kuljarasnont S; Khemworapong K; Jareemit N
    Arch Gynecol Obstet; 2023 Apr; 307(4):1145-1154. PubMed ID: 36116082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curative effect of second curettage for treatment of gestational trophoblastic disease - Results of the Belgian registry for gestational trophoblastic disease.
    Vandewal A; Delbecque K; Van Rompuy AS; Noel JC; Marbaix E; Delvenne P; Nisolle M; Van Nieuwenhuysen E; Kridelka F; Vergote I; Goffin F; Han SN
    Eur J Obstet Gynecol Reprod Biol; 2021 Feb; 257():95-99. PubMed ID: 33383413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E
    Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subsequent pregnancy outcomes after complete and partial molar pregnancy, recurrent molar pregnancy, and gestational trophoblastic neoplasia: an update from the New England Trophoblastic Disease Center.
    Vargas R; Barroilhet LM; Esselen K; Diver E; Bernstein M; Goldstein DP; Berkowitz RS
    J Reprod Med; 2014; 59(5-6):188-94. PubMed ID: 24937955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of uterine re-curettage, pre-evacuation and week-one level of hCG on the number of chemotherapy courses in treatment of post molar GTN.
    Hemida RA; Toson E; Van Doorn HC
    J Exp Ther Oncol; 2011; 9(3):217-20. PubMed ID: 22070053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.